High-Alert Medications and Error Prevention
Educational only, not medical advice. This guide explains general US pharmacy-technician topics. Follow your training, your pharmacist, your state board and the official references for real patients.
Most medication errors cause little or no harm. A small group of drugs is different: when something goes wrong with them, the result is far more likely to be serious. Medication safety experts call these high-alert medications, and the PTCE content outline lists high-alert and look-alike/sound-alike medications as a knowledge area under Patient Safety and Quality Assurance. This guide explains what puts a drug in this group, gives examples from the official lists, and covers the everyday tools pharmacy teams use to keep errors from reaching patients.
What makes a medication high-alert
The Institute for Safe Medication Practices (ISMP) defines high-alert medications as drugs that carry a heightened risk of causing significant patient harm when they are used in error. The key idea is the consequence of an error, not how often errors happen. A mistake with these drugs may not be more common, but it is more likely to hurt someone.
ISMP publishes separate lists for different settings, because the drugs and processes differ:
- Acute care (hospitals), most recently updated in 2024.
- Community/ambulatory care (retail and clinic pharmacies), most recently published in 2021.
- Long-term care, a separate list for those facilities.
For drugs on these lists, ISMP suggests safeguards such as standardizing how they are prescribed, stored, prepared and given; improving access to drug information; limiting access to some of these drugs; using auxiliary labels, clinical decision support and automated alerts; and building in redundancies such as double checks.
Examples from the ISMP lists
These are representative examples, not the complete lists. Always check the current version on the ISMP site.
Acute care list (2024)
- Insulin, all forms, subcutaneous and IV. Insulin U-500 is singled out for special emphasis.
- Anticoagulants, including warfarin, low molecular weight heparin, unfractionated heparin and direct oral anticoagulants.
- Opioids, all routes.
- Potassium chloride for injection concentrate. It must be diluted before IV use. ISMP has warned that concentrate supplied in syringes could be given by IV push by mistake, with possibly fatal results.
- Concentrated sodium chloride injection (stronger than 0.9%).
- Oral methotrexate for non-oncologic use.
Community/ambulatory list (2021)
- Antithrombotic agents, oral and parenteral, including warfarin and heparins.
- All insulins and oral and parenteral chemotherapy (excluding hormonal agents).
- Methotrexate for non-oncologic use, with special emphasis.
- Specific drugs such as carbamazepine, epinephrine (IM and subcutaneous), lamotrigine, phenytoin and valproic acid.
- Drugs that must not be used during pregnancy, such as isotretinoin.
- Pediatric liquid medications that require measurement.
Why U-500 gets extra attention. U-100 insulin contains 100 units per mL, and U-500 contains 500 units per mL, so U-500 is 500 ÷ 100 = 5 times as concentrated. If 0.2 mL is measured:
- From U-100: 0.2 mL × 100 units/mL = 20 units
- From U-500: 0.2 mL × 500 units/mL = 100 units
The same volume delivers five times the dose, so a mix-up between the two strengths is dangerous.
Why oral methotrexate gets extra attention. For non-cancer conditions it is usually taken only once or twice a week. Taking it daily by mistake has caused deaths. ISMP recommends that electronic systems default to weekly dosing, with a hard stop if someone changes an order to daily without a cancer-related reason, and that labels clearly give the weekly schedule, including the day of the week.
Look-alike/sound-alike names and tall man lettering
Many drug names look or sound alike on a label, a screen or over the phone. ISMP keeps a List of Confused Drug Names, and pharmacies use several defenses against these mix-ups.
Tall man lettering puts the parts of two similar names that differ into capital letters, so the eye catches the difference. The FDA's Name Differentiation Project lists established names recommended for tall man lettering, and ISMP publishes a longer, unofficial list. Pairs on the FDA list include:
- hydrALAZINE and hydrOXYzine
- glipiZIDE and glyBURIDE
- busPIRone and buPROPion
- vinBLAStine and vinCRIStine
ISMP notes that the evidence on tall man lettering is mixed, but it still recommends it as one layer of protection. Other LASA defenses include separating similar products on the shelf, using shelf alerts, and including the indication on prescriptions (for example, hydroxyzine "for itching" versus hydralazine "for blood pressure").
The Joint Commission "Do Not Use" list
The Joint Commission keeps a minimum list of abbreviations that must not be used in orders and medication-related documentation, whether handwritten or entered as free text electronically.
| Do not use | Possible problem | Write instead |
|---|---|---|
| U, u (unit) | Can be read as a zero or a 4 | "unit" |
| IU (International Unit) | Can be read as IV | Write it out in full |
| Q.D., QD, q.d., qd; Q.O.D., QOD, q.o.d., qod | Easily confused with each other | "daily"; "every other day" |
| Trailing zero (X.0 mg) | Decimal point can be missed | X mg |
| Missing leading zero (.X mg) | Decimal point can be missed | 0.X mg |
| MS, MSO4, MgSO4 | Could mean morphine sulfate or magnesium sulfate | Write the full drug name |
Worked example: the cost of a missed decimal. An order written "5.0 mg" can be read as 50 mg if the decimal is missed: 50 ÷ 5 = a tenfold overdose. An order written ".5 mg" can be read as 5 mg: 5 ÷ 0.5 = again a tenfold overdose. Writing "5 mg" and "0.5 mg" removes both risks. A trailing zero is acceptable only where precision must be shown, such as lab values, never in medication orders.
Independent double checks
ISMP describes an independent double check as two people separately checking each part of a task. For example, one person calculates a dose and a second person does the same calculation from scratch, rather than just looking over the first person's work, and then the results are compared. If the second person simply reviews the first person's answer, they can easily repeat the same mistake.
ISMP also cautions that independent double checks are not a cure-all. It does not recommend them for every high-alert drug or process, and it sees them as weaker than system fixes such as bar code scanning, standardized concentrations and hard stops in software.
How a technician helps prevent errors
Technicians handle products at many points where errors can start. Practical habits include:
- Scan every product and resolve every bar code mismatch before going on.
- Compare the NDC, strength and dosage form on the stock bottle against the label, not only the drug name.
- Read the whole name. Watch the tall man letters, and never pick a product from its position on the shelf alone.
- Watch the units. Always spell out "units," and pay close attention to insulin concentration and pen or vial type.
- Flag unusual directions to the pharmacist, such as a daily schedule for oral methotrexate or an unclear abbreviation. Clinical judgment belongs to the pharmacist; spotting and raising the issue is your job.
- Report errors and near misses through your pharmacy's reporting process, so the system can be fixed.
Individual state boards of pharmacy and employers may set additional requirements for checks and technician duties.
Key takeaways
- High-alert medications are defined by the severity of harm when an error occurs, not by how often errors happen.
- ISMP keeps separate lists for acute care, community/ambulatory care and long-term care settings.
- Insulin, anticoagulants, opioids, concentrated potassium chloride and oral non-oncologic methotrexate are classic examples.
- Tall man lettering, shelf separation and indications on prescriptions help prevent look-alike/sound-alike mix-ups.
- Never use the abbreviations on The Joint Commission Do Not Use list; write "unit," "daily," and use a leading zero but no trailing zero.
- An independent double check means a truly separate second check, and it works best alongside system safeguards.
Quick check
Q1. A prescription reads "10 U insulin." What is the problem?
Answer: "U" is on the Do Not Use list. It can be misread as a 0, turning 10 units into 100; write "units."
Q2. How much more concentrated is U-500 insulin than U-100?
Answer: Five times. 500 units/mL ÷ 100 units/mL = 5.
Q3. Which is correct: "1.0 mg" or "1 mg"?
Answer: "1 mg." A trailing zero can be missed and read as 10 mg, a tenfold error.
You can practice spotting these hazards in Pillworks Idle.
Sources
- ISMP — List of High-Alert Medications in Acute Care Settings (2024)
- ISMP — List of High-Alert Medications in Community/Ambulatory Care Settings (2021)
- ISMP — List of Error-Prone Abbreviations, Symbols, and Dose Designations (2024)
- FDA — Name Differentiation Project (tall man lettering)
- The Joint Commission — Do Not Use List of Abbreviations
- ISMP — Independent double checks: undervalued and misused (2015)
- ISMP — Medication Safety Alert on accidental daily methotrexate dosing (2018)
- ISMP — Importance of Premarket Labeling and Packaging Safety Evaluations (2021 handout; concentrated potassium chloride in prefilled syringes)
- ISMP — List of Confused Drug Names (2024)
- PTCB — PTCE Job Analysis Study and the content outline effective January 6, 2026